- Home
- ALEC vs TLS Comparison
ALEC vs TLS Comparison
Compare ALEC & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEC | TLS |
|---|---|---|
| Founded | 2013 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.2M | 317.1M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ALEC | TLS |
|---|---|---|
| Price | $2.18 | $4.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $4.83 | ★ $7.90 |
| AVG Volume (30 Days) | 437.9K | ★ 472.2K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.51 |
| EPS | N/A | ★ 0.03 |
| Revenue | $21,045,000.00 | ★ $164,805,000.00 |
| Revenue This Year | $2.03 | $18.72 |
| Revenue Next Year | $29.87 | $14.62 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 52.21 |
| 52 Week Low | $1.01 | $2.37 |
| 52 Week High | $3.40 | $8.36 |
Technical Indicators
Market Signals| Indicator | ALEC | TLS |
|---|---|---|
| Relative Strength Index (RSI) | 42.98 | 49.52 |
| Support Level | $1.89 | $3.88 |
| Resistance Level | $2.57 | $4.61 |
| Average True Range (ATR) | 0.16 | 0.23 |
| MACD | -0.05 | -0.01 |
| Stochastic Oscillator | 24.46 | 31.08 |
Price Performance
Historical ComparisonAbout ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.